Hung Wen Lin Selected Research

Hung Wen Lin Research Topics

Disease

10	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2008
8	Heart Arrest (Cardiac Arrest) 01/2021 - 01/2011
4	Ischemia 03/2018 - 05/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2011
3	Brain Injuries (Brain Injury) 01/2022 - 03/2018
3	Neuroinflammatory Diseases 01/2022 - 11/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2008
2	Memory Disorders (Memory Loss) 01/2022 - 11/2020
2	Stroke (Strokes) 03/2018 - 01/2008
1	Cognitive Dysfunction 01/2022
1	Amyloid Plaque 01/2022
1	Hypertension (High Blood Pressure) 11/2020
1	Hemolytic Anemia 01/2020
1	Hypothermia 03/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2014
1	Infarction (Infarctions) 02/2014
1	Hypoxia (Hypoxemia) 05/2011
1	Inflammation (Inflammations) 04/2011
1	Nervous System Diseases (Neurological Disorders) 01/2008

Drug/Important Bio-Agent (IBA)

4	methyl palmitateIBA 01/2021 - 05/2013
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 05/2013
3	1-phenyl-1-aminomethylethene (PAME)IBA 01/2021 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2020
2	EstersIBA 01/2020 - 02/2014
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2020 - 02/2014
2	ResveratrolIBA 03/2018 - 01/2008
2	Protein Kinase C-deltaIBA 04/2014 - 01/2011
2	Oxygen (Dioxygen)IBA 05/2011 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 05/2011 - 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	CytokinesIBA 01/2022
1	neuropeptide Y2 receptorIBA 01/2022
1	LipidsIBA 01/2022
1	2- cyclopentyl- 4- (5- phenyl- 1H- pyrrolo(2,3- b)pyridin- 3- yl)- benzoic acidIBA 11/2020
1	serum-glucocorticoid regulated kinaseIBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	GlucocorticoidsIBA 11/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2018
1	Protein Kinase CIBA 03/2018
1	NAD (NADH)IBA 03/2018
1	MelatoninIBA 03/2018
1	IsoenzymesIBA 03/2018
1	pifithrinIBA 03/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2018
1	MAZE protocolIBA 01/2018
1	Vasoconstrictor AgentsIBA 01/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2014
1	Vasodilator Agents (Vasodilators)IBA 02/2014
1	Solutol HS 15IBA 02/2014
1	Docosahexaenoic AcidsIBA 05/2013
1	alpha-Linolenic Acid (Linolenic Acid)IBA 05/2013
1	Protein Kinase C-epsilonIBA 05/2011
1	Mitogen-Activated Protein KinasesIBA 05/2011
1	SirtuinsIBA 04/2011
1	Cytochromes c (Cytochrome c)IBA 01/2011
1	Sirtuin 1IBA 01/2008

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2014
2	Induced Heart Arrest (Cardioplegia) 01/2021 - 11/2020
1	Low-Level Light Therapy (LLLT) 01/2022